Multiomics Data Integration With Machine Learning: Methods, Tools, and Biological Applications

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological samples. Because these data types differ wildly in scale, noise, and completeness, analyzing each omics layer in isolation leaves most of the underlying biology on the table. This guide walks through the main machine learning strategies used for multiomics data integration, the tools that implement them, and where the approach is delivering genuine biological insight.

Why multiomics data integration is a hard machine learning problem

Multiomics data integration is difficult primarily because the input data types are fundamentally heterogeneous. Genomic data are largely discrete and static, transcriptomic data are continuous and dynamic across conditions, proteomic data are sparse and affected by detection limits, and metabolomic data carry their own distinct noise structure tied to instrument sensitivity and chemical class. A machine learning model trained to find shared structure across these layers has to reconcile different distributions, different scales, and different missingness patterns before any biological signal can be reliably extracted, and getting this reconciliation wrong can produce integrated representations that reflect measurement artifacts rather than genuine biology.

Sample size compounds the problem in ways that single-omics researchers rarely encounter. Multiomics cohorts are typically smaller than single-omics datasets because collecting several data types from the same biological sample is more expensive, more logistically demanding, and often destructive of limited tissue or sample material. This leaves many multiomics machine learning models working with high-dimensional data and comparatively few samples, a setting in which overfitting is a persistent risk and where batch effects introduced by different profiling platforms, reagent lots, or processing dates can be mistaken for genuine biological variation. This same challenge shapes how machine learning is applied elsewhere in the genomics research pipeline, where cross-platform variability is a recurring source of error.

Researchers evaluating a multiomics data integration method should look closely at how the method's original authors handled small sample regimes and cross-platform batch correction, since these design decisions directly affect the reliability of the low-dimensional representations that most integration methods ultimately produce. A method that performs well on a large, well-controlled benchmark dataset does not automatically generalize to a smaller cohort collected across multiple sites or instruments, and validating any method on data resembling the target application before relying on its output for biological conclusions remains good practice.

Early, intermediate, and late machine learning integration strategies

Machine learning approaches to multiomics data integration are generally grouped into three strategies based on where in the analytical pipeline the different omics layers are combined. Early integration concatenates the raw or lightly processed features from each omics layer into a single matrix before applying any model, which is simple to implement but risks letting the highest-dimensional layer dominate the learned structure and drown out signal from smaller data types such as targeted proteomic panels.

Late integration takes the opposite approach, building a separate model for each omics layer and combining their outputs only at the final prediction or clustering step. This avoids the dominance problem inherent to early integration and makes it straightforward to add or remove an omics layer without retraining the entire pipeline, but it can miss cross-omics interactions that only become visible when the layers are modeled jointly rather than independently.

Intermediate integration sits between these extremes and has become the dominant strategy in recent multiomics machine learning research. Methods in this category learn a shared low-dimensional representation directly from the multiple omics layers, allowing the model to capture cross-omics correlations while still respecting the distinct statistical properties of each data type. Similarity network fusion, an early and influential approach to omics data fusion in this category, builds a separate patient similarity network from each omics layer and then iteratively fuses these networks into a single representation that has been shown to aggregate genomic data types more effectively than analyzing any single data type alone when identifying cancer subtypes and predicting patient survival.

Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO) extends this intermediate integration idea into a supervised framework. The method uses a partial least squares approach to identify key molecular drivers that are correlated across omics layers while simultaneously discriminating between phenotypic groups, making it well suited to biomarker panel discovery when the research question involves a defined clinical or experimental outcome rather than open-ended subtype discovery. Both approaches illustrate a broader pattern in multiomics data integration: methods designed for unsupervised discovery and methods designed for supervised classification tend to make different trade-offs, and choosing between them should be driven by whether the research question already specifies an outcome of interest.

Autoencoders and variational methods for multiomics data integration

Autoencoder-based and variational approaches represent the deep learning branch of intermediate integration and have grown substantially as multiomics datasets, particularly single-cell multiomics datasets, have increased in scale. Multiomics Factor Analysis (MOFA) and its successor built for large single-cell datasets, MOFA+, each function as a multiomics generalization of principal component analysis. The MOFA+ framework reconstructs a low-dimensional representation of the data through an efficient variational inference procedure with adjustable sparsity settings, identifying latent factors that separate variation shared across omics layers from variation specific to a single layer. This decomposition helps researchers distinguish coordinated biological programs, such as a signaling pathway that affects both gene expression and protein abundance together, from technical or layer-specific noise that should not be overinterpreted.

Variational autoencoder architectures extend this probabilistic framework further using deep neural networks rather than linear factor models. A deep generative model built for jointly profiled transcriptome and chromatin accessibility data creates a joint multimodal representation that allows analysis of every included modality, even for cells in which one modality was not measured. This addresses a practical limitation common to single-cell multiomics experiments, in which technical constraints often mean only a subset of profiled cells receive complete measurements across every modality, leaving the remainder with partial data that earlier integration methods struggled to use.

The trade-off researchers face when choosing between matrix factorization and deep autoencoder approaches largely comes down to dataset size and interpretability requirements. Matrix factorization methods produce factors that can be directly linked back to specific genes, proteins, or metabolites, which supports biological interpretation even when a cohort is relatively small. Deep autoencoder methods generally require larger training sets to learn stable representations but can capture nonlinear relationships between omics layers that linear factor models cannot represent, an advantage that becomes more pronounced as single-cell multiomics cohorts continue to grow into the tens or hundreds of thousands of cells.

Graph neural networks and key tools for multiomics data integration

Graph-based integration methods represent a further extension of intermediate integration, modeling samples or molecular features as nodes in a network rather than as rows in a factorized matrix, an approach that has become increasingly relevant to integrative genomics research as prior knowledge networks have grown more complete. This framing allows a model to incorporate prior biological knowledge, such as known protein interaction networks or curated pathway membership, directly into the integration process, something that is considerably harder to build into a purely statistical factorization approach without substantial custom engineering.

Multiomics Graph cOnvolutional NETworks (MOGONET) illustrates this approach concretely. The method trains a separate graph convolutional network on each omics layer using a sample similarity network constructed from that layer's data, then combines the resulting layer-specific predictions into a cross-omics discovery tensor that a dedicated correlation-discovery network processes to produce a final classification. In benchmark comparisons across several disease classification tasks, this graph-based framework was shown to outperform supervised integration approaches built on more conventional statistical methods, while also supporting biomarker identification directly from the learned graph structure. This gives researchers both a predictive model and a route back to biologically interpretable features, a combination that purely predictive deep learning models do not always provide.

Table 1: Major machine learning strategies for multiomics data integration, grouped by technical approach.

Selecting among these bioinformatics tools in practice depends on a small number of recurring considerations that are worth working through before committing to a specific multiomics data integration pipeline:

1. Confirm whether the research question is primarily discovery-oriented, such as unsupervised subtype or factor discovery, or classification-oriented, such as predicting a known phenotype or clinical outcome, since this determines whether an unsupervised method such as MOFA+ or a supervised method such as DIABLO is the more appropriate starting point.
2. Check how each candidate method handles missing modalities, since few real-world multiomics cohorts have complete data for every sample across every omics layer, and methods vary considerably in how gracefully they degrade with partial data.
3. Evaluate the available sample size against the method's typical training requirements, favoring matrix factorization approaches for smaller cohorts and deep learning approaches once cohort size supports stable model training without excessive overfitting.
4. Assess whether incorporating prior biological network knowledge, such as protein interaction data or curated pathway annotations, would meaningfully improve interpretation, since this consideration favors graph-based methods over purely statistical factorization approaches.

Biological applications of multiomics data integration

The practical payoff of multiomics data integration is clearest in disease subtyping and biomarker discovery, where no single molecular layer fully captures the heterogeneity researchers observe in complex diseases such as cancer. A genomic mutation, a corresponding shift in gene expression, and a downstream change in protein abundance can each tell part of the same biological story, and integration methods exist precisely to recover that shared story rather than analyzing each layer separately and hoping the resulting conclusions happen to align.

Synthetic Biology: Engineering Life

This infographic provides a clear overview of the workflow, technologies, and applications shaping synthetic biology.
View Infographic

Advertisement

Much of the methodological progress described in this guide has been developed and benchmarked using large, publicly available multiomics resources. The Cancer Genome Atlas, coordinated by the National Cancer Institute and the National Human Genome Research Institute, profiled genomic, transcriptomic, proteomic, and epigenetic data from thousands of tumors across dozens of cancer types, and its public availability has made it a standard benchmark for nearly every multiomics integration method covered in this guide. Researchers developing new integration methods routinely validate against this resource before applying their approach to smaller, disease-specific cohorts, which gives the broader field a shared point of comparison that is otherwise difficult to establish across a landscape of heterogeneous data types.

Beyond bulk tumor profiling, multiomics integration is increasingly applied at single-cell resolution, extending the same core integration challenge down to individual cells rather than bulk tissue samples. Technologies that jointly profile gene expression alongside chromatin accessibility, or gene expression alongside surface protein abundance, generate exactly the kind of paired multimodal single-cell data that motivated the deep generative integration methods discussed earlier. This resolution matters biologically because it allows researchers to ask not just which molecular changes co-occur across a tissue on average, but which specific cell types or cell states carry a given multiomics signature, a question closely related to the cell type annotation challenges covered in guides on single-cell RNA sequencing analysis.

Researchers applying these methods to their own data should treat multiomics data integration as an evolving toolkit rather than a solved problem with one correct answer. Method choice should be driven by the specific biological question, the completeness and scale of the available data, and whether interpretability or predictive performance is the higher priority for a given study, rather than by which tool happens to be most widely cited or most recently published.

Choosing the right approach to multiomics data integration

Multiomics data integration with machine learning has matured from a niche statistical exercise into a standard part of the computational biology toolkit, with matrix factorization, deep generative, and graph-based methods each addressing the core challenge of heterogeneous, incomplete data from a different technical angle. This progress builds directly on the broader shift toward AI and data science as core research infrastructure across life science disciplines, rather than as a specialized add-on reserved for computational groups alone.

No single multiomics integration method has emerged as universally superior, and the practical differences between early, intermediate, and late integration strategies remain directly relevant to how a given dataset should be approached. Researchers who understand the trade-offs between interpretability, sample size requirements, and the ability to handle missing modalities will be better positioned to select a multiomics data integration method that matches their actual research question, rather than adopting a tool simply because it is the most familiar or most recently published option available.

This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.